You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Medscape Perspectives on the American Psychiatric Association (APA) 161st Annual Meeting

May 03 - 08, 2008

This activity is not sanctioned by, nor a part of, the American Psychiatric Association. Conference news does not receive grant support and is produced independently.


Topic Overviews

  • Physicians - maximum of 1.25 AMA PRA Category 1 credit(s)™
    Nurses - 1.25 nursing contact hours (1.0 of these credits are in the area of pharmacology)
    Pharmacists - 1.25 ACPE continuing education credits for pharmacists (0.125 CEUs)
    • Child and Adolescent ADHD: An Update on Pharmacotherapy
      Paul G. Hammerness, MD; Alisa R. Gutman, PhD
    • Pharmacotherapy of Adult ADHD
      Craig B.H. Surman, MD
    • Comorbidity in Adult ADHD
      Craig B.H. Surman, MD
  • Physicians - maximum of 1.0 AMA PRA Category 1 credit(s)™
    • Advances in Bipolar Disorder Detection and Management
      Zubin Bhagwagar, MD, PhD
    • New Findings in Childhood Bipolar Disorder
      Zubin Bhagwagar, MD, PhD
  • Physicians - maximum of 2.0 AMA PRA Category 1 credit(s)™
    Nurses - 2.0 nursing contact hours (0.5 of these credits are in the area of pharmacology)
    Pharmacists - 2.0 ACPE continuing education credits for pharmacists (0.2 CEUs)
    • New Research on Pharmacotherapy of Major Depression
      Michael E. Thase, MD
    • Treatment-Refractory Depression
      Jerrold F. Rosenbaum, MD; Jennifer M. Covino, MPA
    • Neurobiology and Genetics of Depression
      Jerrold F. Rosenbaum, MD; Jennifer M. Covino, MPA
    More...
  • Physicians - maximum of 1.25 AMA PRA Category 1 credit(s)™
    • Advances in the Early Detection and Prevention of Schizophrenia
      Michael T. Compton, MD, MPH
    • Contemporary and Emerging Approaches to Treating Schizophrenia
      Michael T. Compton, MD, MPH
    • Advances in the Pharmacogenetics of Serious Mental Illnesses
      Michael T. Compton, MD, MPH

Expert Interviews